Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

COVID-19 vaccinations continue to decline in the U.S.

By Brian Buntz | June 24, 2021

COVID-19 therapies vaccines coronavirus

[Photo by Daniel Schludi on Unsplash]

The pace of COVID-19 vaccination in the U.S. continues to fall. Today, the U.S. administered about 600,000 COVID-19 vaccine doses, which is far fewer than two months ago.

At the mid-April peak, healthcare workers administered more than 3 million COVID-19 vaccine doses. The pace of vaccination fell steadily from that time to early June before stabilizing at around 1 million doses per day.

Complicating matters is the spread of the Delta variant (B.1.617.2), which ravaged India. The variant is now dominant in the U.K. and Europe, threatening to undermine the return to normalcy there.

According to a preprint study, the Delta variant could become dominant in the U.S. within a matter of weeks. Indeed, the variant already is the cause of almost half of COVID-19 infections in some Midwest and mountain states, said CDC Director Dr. Rochelle Walensky in a briefing on Tuesday.

Researchers have concluded that the Delta variant is considerably more contagious than the Alpha variant (B.1.1.7) and the strain that first emerged from Wuhan.

The rise of the Delta variant “increases the impetus to drive vaccination rates higher (putting countries with lower vaccine access at greater risk),” concluded UBS analyst Dan Brennan in a briefing note.

The variant could also influence government authorities’ decisions regarding the need for boosters in the fall. While a committee of CDC scientists concluded more data are needed to recommend boosters to the overall population, immunocompromised and elderly patients will likely benefit from boosters.

Both Moderna (NSDQ:MRNA) and Pfizer (NYSE:PFE) are developing COVID-19 boosters.


Filed Under: Infectious Disease
Tagged With: Alpha variant, B.1.1.7, B.1.617.2, CDC, coronavirus, covid-19, COVID-19 vaccination, COVID-19 vaccine, COVID-19 vaccines, Delta variant, U.S. Centers for Disease Control and Prevention (CDC)
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Close-up medical syringe with a vaccine.
Six leading medical organizations sue RFK Jr. over vaccine recommendations
RFK’s new ACIP changed longstanding vaccine recommendations
Secretary of Health removes all current members of the CDC advisory committee on immunization practices
covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE